Associated Papers
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer.
Cencic R et al.
Proceedings of the National Academy of Sciences of the United States of America, 2024
Functional mimicry revealed by the crystal structure of an eIF4A:RNA complex bound to the interfacial inhibitor, desmethyl pateamine A.
Naineni SK et al.
Cell Chemical Biology, 2021
Select a paper to view details